Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 77 peer-reviewed journal articles Updated
Hematology

Deafness-Lymphedema-Leukemia Syndrome (Emberger Syndrome): A Patient Guide

At a Glance

Emberger syndrome is a rare genetic condition caused by a change in the GATA2 gene. It can affect hearing, lymphatic drainage, immune cells, and bone marrow, so regular monitoring helps identify infections, blood disorders, and when transplant may be needed.

Deafness-Lymphedema-Leukemia Syndrome, often called Emberger Syndrome, is a rare genetic condition that affects several of the body’s vital systems simultaneously [1]. It is caused by a pathogenic variant (mutation) in the GATA2 gene, which serves as a master instruction manual for developing healthy blood cells, a strong immune system, and the lymphatic vessels that move fluid throughout the body [2][3]. Because this gene is essential for so many different jobs, you or your child may experience a wide range of symptoms that initially seem unrelated, such as hearing loss, chronic swelling, and a vulnerability to infections [4][5].

What Varies from Person to Person: Symptoms and disease progression vary widely. Hearing loss, lymphedema, cytopenias, infections, and bone marrow changes do not occur in every person, and there is no fixed timeline for when they might appear.

The condition is often first recognized through its physical features, particularly sensorineural hearing loss (which is frequently present from birth or early childhood) and primary lymphedema, a type of chronic swelling that typically affects the legs [6][7]. While these symptoms can be life-altering, the most critical aspect of the syndrome is how it affects the bone marrow and the immune system [8]. People with Emberger syndrome often have a severe shortage of specific white blood cells, such as monocytes, B cells, and Natural Killer (NK) cells, making them susceptible to “opportunistic” infections like persistent warts (HPV) or unusual bacteria [9][10].

Over time, the fragile state of the bone marrow can lead to more serious complications, including Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [11][12]. This risk to the blood-forming “factory” is the reason why doctors emphasize regular, individualized monitoring and why an allogeneic hematopoietic stem cell transplant is often considered the definitive treatment for severe hematologic or immune disease [13][14]. Although the journey can be complex, understanding the genetic root of the condition allows your medical team to be proactive, focusing on preventing infections and intervening at the optimal time to protect long-term health [15][16].

In this guide

6 chapters

01

Understanding Emberger Syndrome (GATA2 Deficiency)

Learn about Emberger syndrome (GATA2 deficiency), including hearing loss, lymphedema, infection risks, bone marrow monitoring, genetic testing, and treatment.

02

The Biology and Diagnosis of GATA2 Deficiency

Learn how GATA2 deficiency causes immune and blood-cell problems, how germline testing confirms Emberger syndrome, and why family screening matters for care.

03

Symptoms, Infections, and Warning Signs

Learn about Emberger syndrome symptoms, including hearing loss, lymphedema, serious infections, lung problems, and warning signs requiring urgent care.

04

Bone Marrow Health, Leukemia Risk, and Monitoring

Learn how Emberger syndrome (GATA2 deficiency) affects bone marrow, MDS and AML risk, and monitoring with blood counts, biopsies, and mutation testing.

05

Treatment Strategies and Stem Cell Transplant

Learn when Emberger syndrome may require a stem cell transplant, how donor testing and conditioning work, and major risks such as GVHD and fertility effects.

06

Building Your Care Team and Daily Management

Learn how Emberger syndrome care teams manage hearing loss, lymphedema, infections, dental safety, and daily red-flag checks in GATA2 deficiency management.

Common questions in this guide

What is Emberger syndrome?
Emberger syndrome, also called deafness-lymphedema-leukemia syndrome, is a rare genetic condition caused by a harmful change in the GATA2 gene. The gene helps support the development of blood cells, immune defenses, and lymphatic vessels, so the condition can affect several body systems.
What symptoms can occur with Emberger syndrome?
Possible features include sensorineural hearing loss, often from birth or early childhood, and primary lymphedema that causes chronic leg swelling. Some people also have low blood-cell counts, bone marrow changes, or unusual and recurrent infections, but symptoms and timing vary widely.
How is Emberger syndrome diagnosed?
Doctors may suspect the condition when hearing loss, primary lymphedema, low blood-cell counts, infections, or bone marrow findings occur together. Germline GATA2 genetic testing can confirm a disease-causing variant, while blood counts and bone marrow evaluations help assess its effects.
Why are infections a concern with Emberger syndrome?
Emberger syndrome can cause severe shortages of monocytes, B cells, and natural killer cells, which are important parts of immune defense. This can increase vulnerability to opportunistic infections, including persistent HPV-related warts and unusual bacterial infections.
Can Emberger syndrome lead to leukemia?
Bone marrow problems associated with the syndrome can lead to myelodysplastic syndrome or acute myeloid leukemia over time. This does not mean that every person will develop leukemia, and individualized blood counts, immune monitoring, and bone marrow follow-up help guide care.
When might a stem cell transplant be considered?
An allogeneic hematopoietic stem cell transplant may be considered when the syndrome causes severe blood or immune-system disease. The medical team weighs disease severity, test results, potential risks, and timing for each person.
How can infection risk be managed in Emberger syndrome?
Care includes an individualized plan for monitoring immune-cell counts and watching for infections. Depending on a person’s results and treatment plan, clinicians may discuss vaccinations or preventive medicines, along with precautions to reduce exposure to infections.

Get notified when new evidence is published on Deafness-lymphedema-leukemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    GATA 2 Deficiency: Focus on Immune System Impairment.

    Fabozzi F, Mastronuzzi A, Ceglie G, et al.

    Frontiers in immunology 2022; (13()):865773 doi:10.3389/fimmu.2022.865773.

    PMID: 35769478
  2. 2

    Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.

    Wu Z, Gao S, Diamond C, et al.

    Blood advances 2020; (4(12)):2656-2670 doi:10.1182/bloodadvances.2019001352.

    PMID: 32556286
  3. 3

    The different faces of GATA2 deficiency: implications for therapy and surveillance.

    Vinci L, Strahm B, Speckmann C, Erlacher M

    Frontiers in oncology 2024; (14()):1423856 doi:10.3389/fonc.2024.1423856.

    PMID: 38993648
  4. 4

    A pluripotent stem cell model of Emberger syndrome reveals reduced lymphatic endothelial differentiation.

    Kouzuki K, Umeda K, Hamabata T, et al.

    International journal of hematology 2025; (122(4)):590-597 doi:10.1007/s12185-025-04004-1.

    PMID: 40434572
  5. 5

    GATA2 deficiency and related myeloid neoplasms.

    Wlodarski MW, Collin M, Horwitz MS

    Seminars in hematology 2017; (54(2)):81-86 doi:10.1053/j.seminhematol.2017.05.002.

    PMID: 28637621
  6. 6

    Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation.

    Rastogi N, Abraham RS, Chadha R, et al.

    Journal of pediatric hematology/oncology 2018; (40(6)):e383-e388 doi:10.1097/MPH.0000000000000995.

    PMID: 29189513
  7. 7

    GATA2 is required for lymphatic vessel valve development and maintenance.

    Kazenwadel J, Betterman KL, Chong CE, et al.

    The Journal of clinical investigation 2015; (125(8)):2979-94.

    PMID: 26214525
  8. 8

    Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.

    Kotmayer L, Kozyra EJ, Kang G, et al.

    Blood cancer journal 2025; (15(1)):121 doi:10.1038/s41408-025-01309-6.

    PMID: 40664679
  9. 9

    Germline GATA2 Mutation and Bone Marrow Failure.

    McReynolds LJ, Calvo KR, Holland SM

    Hematology/oncology clinics of North America 2018; (32(4)):713-728 doi:10.1016/j.hoc.2018.04.004.

    PMID: 30047422
  10. 10

    Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.

    Nováková M, Žaliová M, Suková M, et al.

    Haematologica 2016; (101(6)):707-16 doi:10.3324/haematol.2015.137711.

    PMID: 27013649
  11. 11

    GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.

    Rajput RV, Arnold DE

    Current hematologic malignancy reports 2023; (18(4)):89-97 doi:10.1007/s11899-023-00695-7.

    PMID: 37247092
  12. 12

    GATA2 deficiency syndrome: A decade of discovery.

    Homan CC, Venugopal P, Arts P, et al.

    Human mutation 2021; (42(11)):1399-1421 doi:10.1002/humu.24271.

    PMID: 34387894
  13. 13

    Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium.

    Sicre de Fontbrune F, Chevillon F, Fahd M, et al.

    British journal of haematology 2026; (208(1)):250-258 doi:10.1111/bjh.19691.

    PMID: 39159950
  14. 14

    Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.

    Bortnick R, Wlodarski M, de Haas V, et al.

    Bone marrow transplantation 2021; (56(11)):2732-2741 doi:10.1038/s41409-021-01374-y.

    PMID: 34244664
  15. 15

    The spectrum of GATA2 deficiency syndrome.

    Calvo KR, Hickstein DD

    Blood 2023; (141(13)):1524-1532 doi:10.1182/blood.2022017764.

    PMID: 36455197
  16. 16

    Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS.

    Saida S, Umeda K, Yasumi T, et al.

    Pediatric transplantation 2016; (20(2)):333-6 doi:10.1111/petr.12667.

    PMID: 26748574

This page explains Emberger syndrome for informational purposes only and does not constitute medical advice. Your hematology and genetics team should interpret GATA2 testing and guide monitoring, infection prevention, and transplant decisions.